Literature DB >> 14583867

Pneumonia in older persons.

Mark Loeb1.   

Abstract

Community-acquired pneumonia (CAP) is an important threat to the health of older adults. Streptococcus pneumonia remains the most important cause of CAP. Risk factors for CAP include alcoholism, asthma, immunosuppression, chronic respiratory or cardiac disease, institutionalization, and increasing age. Residents of long-term care facilities--a distinct subpopulation of elderly people--are at particularly high risk for developing pneumonia. In this setting, swallowing difficulties, witnessed aspiration, and receipt of sedatives are potentially modifiable risk factors. The clinical presentation in elderly patients is characterized by a reduced prevalence of nonrespiratory symptoms. Few randomized, controlled trials of therapy exist for elderly persons living in the community or in a long-term care setting. Good evidence exists to support the annual administration of influenza vaccine to older adults. Although evidence in clinical trials differs from evidence in observational studies that demonstrate clear benefits associated with the polysaccharide pneumococcal vaccine in this population, the vaccine is recommended for adults aged

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583867     DOI: 10.1086/379076

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

2.  Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae.

Authors:  Truc Thanh Luong; Eun-Hye Kim; Jong Phil Bak; Cuong Thach Nguyen; Sangdun Choi; David E Briles; Suhkneung Pyo; Dong-Kwon Rhee
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 3.  Nursing home-acquired pneumonia: update on treatment options.

Authors:  Joseph M Mylotte
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older.

Authors:  Kathleen W Wyrwich; Holly Yu; Reiko Sato; David Strutton; John H Powers
Journal:  Patient       Date:  2013       Impact factor: 3.883

Review 5.  Pneumonia in frail older patients: an up to date.

Authors:  Marco Falcone; Francesco Blasi; Francesco Menichetti; Federico Pea; Francesco Violi
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

6.  Diagnosing community-acquired pneumonia via a smartphone-based algorithm: a prospective cohort study in primary and acute-care consultations.

Authors:  Paul Porter; Joanna Brisbane; Udantha Abeyratne; Natasha Bear; Javan Wood; Vesa Peltonen; Phillip Della; Claire Smith; Scott Claxton
Journal:  Br J Gen Pract       Date:  2021-03-26       Impact factor: 5.386

7.  Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study.

Authors:  Binod Neupane; Stephen D Walter; Paul Krueger; Tom Marrie; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-05-11       Impact factor: 3.921

Review 8.  Value of RVP in clinical settings: older adults.

Authors:  Cathy A Petti; David Hillyard
Journal:  J Clin Virol       Date:  2007-11       Impact factor: 3.168

9.  Prognosis of primary care patients aged 80 years and older with lower respiratory tract infection.

Authors:  Christiana van de Nadort; Hugo M Smeets; Jettie Bont; N Peter A Zuithoff; Eelko Hak; Theo J M Verheij
Journal:  Br J Gen Pract       Date:  2009-04       Impact factor: 5.386

10.  Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada.

Authors:  Samir N Patel; Roberto Melano; Allison McGeer; Karen Green; Donald E Low
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-18       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.